WMT

98.44

+0.98%↑

COST

986.63

+0.52%↑

KR

69.84

-0.85%↓

TGT

104.2

-0.33%↓

GIS

53.14

-0.75%↓

WMT

98.44

+0.98%↑

COST

986.63

+0.52%↑

KR

69.84

-0.85%↓

TGT

104.2

-0.33%↓

GIS

53.14

-0.75%↓

WMT

98.44

+0.98%↑

COST

986.63

+0.52%↑

KR

69.84

-0.85%↓

TGT

104.2

-0.33%↓

GIS

53.14

-0.75%↓

WMT

98.44

+0.98%↑

COST

986.63

+0.52%↑

KR

69.84

-0.85%↓

TGT

104.2

-0.33%↓

GIS

53.14

-0.75%↓

WMT

98.44

+0.98%↑

COST

986.63

+0.52%↑

KR

69.84

-0.85%↓

TGT

104.2

-0.33%↓

GIS

53.14

-0.75%↓

Search

Lifecore Biomedical Inc

Geschlossen

BrancheKonsumgüter defensiv

8

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

7.9

Max

8.01

Schlüsselkennzahlen

By Trading Economics

Einkommen

-8.2M

-15M

Verkäufe

2.6M

35M

KGV

Branchendurchschnitt

201.137

27.516

EPS

-0.253

Gewinnspanne

-42.012

Angestellte

524

EBITDA

-5.5M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+11.94% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

22. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

84M

258M

Vorheriger Eröffnungskurs

8

Vorheriger Schlusskurs

8

Nachrichtenstimmung

By Acuity

17%

83%

9 / 150 Ranking in Consumer defensive

Lifecore Biomedical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

6. Juli 2025, 23:55 UTC

Market Talk

Gold Edges Lower on Possible Position Adjustments -- Market Talk

6. Juli 2025, 22:35 UTC

Akquisitionen, Fusionen, Übernahmen

South32 Expects to Complete Transaction in Late 2025

6. Juli 2025, 22:35 UTC

Akquisitionen, Fusionen, Übernahmen

South32: CoreX to Make Future Cash Payments of Up to US$100 Million for Cerro Matoso

6. Juli 2025, 22:34 UTC

Akquisitionen, Fusionen, Übernahmen

South32 Agrees to Sell Cerro Matoso Nickel Operation to Unit of CoreX Holding

5. Juli 2025, 04:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

4. Juli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

4. Juli 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4. Juli 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

4. Juli 2025, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

4. Juli 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

4. Juli 2025, 16:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

4. Juli 2025, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4. Juli 2025, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

4. Juli 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

4. Juli 2025, 15:57 UTC

Market Talk

Base Metal Prices Fall in Thin, Risk-off Trading -- Market Talk

4. Juli 2025, 15:49 UTC

Market Talk

Gold Futures Set to End Week Flat After Mixed Jobs Report -- Market Talk

4. Juli 2025, 15:49 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole: Deal Will Have a Negative Impact of Approximately 30 Basis Points on the Fully-Loaded CET1 Ratio

4. Juli 2025, 15:49 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole: Transaction Is Consistent With Targets in Terms of Return of Investment, Return on Tangible Equity

4. Juli 2025, 15:49 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole Received All Required Authorizations

4. Juli 2025, 15:48 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole: CACEIS and Santander Are Maintaining Their Long-Term Partnership

4. Juli 2025, 15:47 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole: Agreement Was Announced on Dec. 19

4. Juli 2025, 15:47 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole Now Controls 100% of the Share Capital of CACEIS

4. Juli 2025, 15:46 UTC

Akquisitionen, Fusionen, Übernahmen

Credit Agricole Completes Acquisition of Santander's 30.5% Stake in CACEIS

4. Juli 2025, 14:30 UTC

Akquisitionen, Fusionen, Übernahmen

Rocky Shore Closes Hemlo Area Claims Sale to Barrick Mining Unit for C$975,000 Cash

4. Juli 2025, 13:53 UTC

Market Talk

Polish Zloty Faces Hit From Prospect of Further Rate Cuts -- Market Talk

4. Juli 2025, 13:41 UTC

Market Talk

Japanese Yen Could Receive Boost From Increased Rate-Hike Bets -- Market Talk

4. Juli 2025, 13:41 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

4. Juli 2025, 13:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

4. Juli 2025, 12:37 UTC

Market Talk

Fund Manager Roundup: U.S. Treasurys in Focus Amid Rising Debt

4. Juli 2025, 12:37 UTC

Market Talk

Fund Manager Roundup: U.S. Treasurys in Focus -2-

Peer-Vergleich

Kursveränderung

Lifecore Biomedical Inc Prognose

Kursziel

By TipRanks

11.94% Vorteil

12-Monats-Prognose

Durchschnitt 9 USD  11.94%

Hoch 9 USD

Tief 9 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Lifecore Biomedical Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

2

Buy

0

Halten

0

Sell

Stimmung

By Acuity

9 / 150 Ranking in Konsumgüter defensiv

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Durchschnitt

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.